Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2013 07:45 ET | Source: Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Announces Post-Merger Leadership Changes and Strategic Restructuring

VICTORIA, British Columbia, Oct. 22, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc., now operating as Aurinia Pharmaceuticals Inc. (TSX-V:ISA) ("Aurinia" or the "Company"), announced today a...
September 26, 2013 08:00 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Pharma Inc. Common Shares to Commence Trading on the TSX-V as of September 30, 2013

VICTORIA, British Columbia, Sept. 26, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc., now operating as Aurinia Pharmaceuticals Inc. (TSX:ISA) ("Aurinia" or the "Company"), announced that, further to...
September 23, 2013 08:00 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika and Aurinia Complete Merger and Financing

VICTORIA, British Columbia, Sept. 23, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (the "Company") announced today that it has completed the merger and related transactions (the "Merger...
August 16, 2013 08:30 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Shareholders Approve Merger With Aurinia at Annual and Special Meeting

EDMONTON, Alberta, Aug. 16, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") announced that at its Annual and Special Meeting of Shareholders held on August...
August 13, 2013 18:46 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Reports Second Quarter 2013 Financial Results

EDMONTON, Alberta, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (the "Company") has released its financial results for the second quarter ended June 30, 2013. Recent...
July 25, 2013 08:30 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika to Hold Annual and Special Meeting of Shareholders on August 15

EDMONTON, Alberta, July 25, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") and privately-held Aurinia Pharmaceuticals Inc. ("Aurinia") issued a further...
June 27, 2013 07:45 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Provides Further Merger and Financings Update

EDMONTON, Alberta, June 27, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") and privately-held Aurinia Pharmaceuticals Inc. ("Aurinia") issued a further...
June 18, 2013 07:45 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Pharma Receives Additional Funding From the Government of Canada for the Preclinical Development of NICAM 440-02 as an Anti-Hepatitis C Agent

EDMONTON, Alberta, June 18, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") today announced that it has received additional funding from the National...
May 15, 2013 17:00 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Reports First Quarter 2013 Financial Results

EDMONTON, Alberta, May 15, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (the "Company") has released its financial results for the first quarter ended March 31, 2013. Recent...
April 17, 2013 08:25 ET | Source: Aurinia Pharmaceuticals Inc.

Isotechnika Provides Merger Update and Announces Financings

EDMONTON, Alberta, April 17, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") and privately-held Aurinia Pharmaceuticals Inc. ("Aurinia") issued an update...